Tumor Biology

, Volume 36, Issue 5, pp 3751–3756 | Cite as

RBPJ inhibition impairs the growth of lung cancer

Research Article


The exact effects of the modulation of Notch signaling pathway on cell growth have been shown to depend on tumor cell type. Recombination signal-binding protein Jκ (RBPJ) is a key transcription factor downstream of receptor activation in Notch signaling pathway. Here, we evaluated the effects of RBPJ inhibition on the growth of lung cancer cells. We found that a short hairpin interfering RNA (shRNA) for RBPJ efficiently inhibited RBPJ expression in lung cancer cells, resulting in a significant decrease in the cell growth. Further analyses showed that RBPJ inhibition altered the levels of its downstream targets, including p21, p27, CDK2, Hes1, Bcl-2, and SKP2, to prevent the cells from growing. Our data thus suggest that shRNA intervention of RBPJ expression could be a promising therapeutic approach for treating human lung cancer.


RBPJ Cancer growth Lung cancer Notch signaling pathway 


  1. 1.
    Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5:S389–96.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Mitsudomi T, Suda K, Yatabe Y. Surgery for nsclc in the era of personalized medicine. Nat Rev Clin Oncol. 2013;10:235–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Pallis AG, Syrigos KN. Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC. Lung Cancer. 2013;80:120–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Jian H, Zhao Y, Liu B, Lu S. SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer. Tumour Biol. 2014;35:11051–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Pei J, Lou Y, Zhong R, Han B. MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35:6673–8.CrossRefPubMedGoogle Scholar
  6. 6.
    6 Wang W, Wu X, Tian Y: Crosstalk of AP4 and TGFbeta receptor signaling in NSCLC. Tumour Biol 2014.Google Scholar
  7. 7.
    Hu YY, Zheng MH, Zhang R, Liang YM, Han H. Notch signaling pathway and cancer metastasis. Adv Exp Med Biol. 2012;727:186–98.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang Z, Li Y, Banerjee S, Sarkar FH. Exploitation of the notch signaling pathway as a novel target for cancer therapy. Anticancer Res. 2008;28:3621–30.PubMedGoogle Scholar
  9. 9.
    Hsieh JJ, Hayward SD. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science. 1995;268:560–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Castel D, Mourikis P, Bartels SJ, Brinkman AB, Tajbakhsh S, Stunnenberg HG. Dynamic binding of RBPJ is determined by notch signaling status. Genes Dev. 2013;27:1059–71.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hori K, Cholewa-Waclaw J, Nakada Y, Glasgow SM, Masui T, Henke RM, et al. A nonclassical bHLH Rbpj transcription factor complex is required for specification of GABAergic neurons independent of notch signaling. Genes Dev. 2008;22:166–78.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Guo D, Ye J, Dai J, Li L, Chen F, Ma D, et al. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res. 2009;33:678–85.CrossRefPubMedGoogle Scholar
  13. 13.
    Gao F, Yao M, Shi Y, Hao J, Ren Y, Liu Q, et al. Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways. J Cell Biochem. 2013;114:1029–38.CrossRefPubMedGoogle Scholar
  14. 14.
    Jarriault S, Le Bail O, Hirsinger E, Pourquie O, Logeat F, Strong CF, et al. Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol. 1998;18:7423–31.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D, et al. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in t-cell acute lymphoblastic leukemia cell lines. Exp Cell Res. 2007;313:3141–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Nakamura T, Miyagawa S, Katsu Y, Mizutani T, Sato T, Takeuchi T, et al. P21 and notch signalings in the persistently altered vagina induced by neonatal diethylstilbestrol exposure in mice. J Vet Med Sci. 2012;74:1589–95.CrossRefPubMedGoogle Scholar
  17. 17.
    Marcelo KL, Sills TM, Coskun S, Vasavada H, Sanglikar S, Goldie LC, et al. Hemogenic endothelial cell specification requires c-Kit, notch signaling, and p27-mediated cell-cycle control. Dev Cell. 2013;27:504–15.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Harashima H, Dissmeyer N, Schnittger A. Cell cycle control across the eukaryotic kingdom. Trends Cell Biol. 2013;23:345–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Teixeira LK, Reed SI. Ubiquitin ligases and cell cycle control. Annu Rev Biochem. 2013;82:387–414.CrossRefPubMedGoogle Scholar
  20. 20.
    Maraver A, Fernandez-Marcos PJ, Herranz D, Canamero M, Munoz-Martin M, Gomez-Lopez G, et al. Therapeutic effect of gamma-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell. 2012;22:222–34.CrossRefPubMedGoogle Scholar
  21. 21.
    Wang YC, He F, Feng F, Liu XW, Dong GY, Qin HY, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010;70:4840–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Hu XB, Feng F, Wang YC, Wang L, He F, Dou GR, et al. Blockade of notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia. 2009;11:32–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Dou GR, Wang YC, Hu XB, Hou LH, Wang CM, Xu JF, et al. RBP-J, the transcription factor downstream of notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J. 2008;22:1606–17.CrossRefPubMedGoogle Scholar
  24. 24.
    Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, et al. RBPJ is a novel target for rhabdomyosarcoma therapy. PLoS One. 2012;7:e39268.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational sirna design for rna interference. Nat Biotechnol. 2004;22:326–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci U S A. 2014;111:E1211–1220.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger PP. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle. 2010;9:689–99.CrossRefPubMedGoogle Scholar
  28. 28.
    Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat. 2007;10:13–29.CrossRefPubMedGoogle Scholar
  29. 29.
    Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003;13:65–70.CrossRefPubMedGoogle Scholar
  30. 30.
    Tang Y, Hu C, Yang H, Cao L, Li Y, Deng P, et al. Rnd3 regulates lung cancer cell proliferation through notch signaling. PLoS One. 2014;9:e111897.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Theys J, Yahyanejad S, Habets R, Span P, Dubois L, Paesmans K, et al. High notch activity induces radiation resistance in non small cell lung cancer. Radiother Oncol. 2013;108:440–5.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, et al. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res. 2013;19:1972–80.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Xie M, Liu M, He CS. Sirt1 regulates endothelial notch signaling in lung cancer. PLoS One. 2012;7:e45331.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Xie M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, et al. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem. 2012;113:1501–13.PubMedGoogle Scholar
  35. 35.
    Ji X, Wang Z, Geamanu A, Sarkar FH, Gupta SV. Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation. J Cell Biochem. 2011;112:2773–83.CrossRefPubMedGoogle Scholar
  36. 36.
    Galluzzo P, Bocchetta M. Notch signaling in lung cancer. Expert Rev Anticancer Ther. 2011;11:533–40.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Garcia Campelo MR, Alonso Curbera G, Aparicio Gallego G, Grande Pulido E, Anton Aparicio LM. Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin Transl Oncol. 2011;13:77–83.CrossRefPubMedGoogle Scholar
  38. 38.
    Westhoff B, Colaluca IN, D’Ario G, Donzelli M, Tosoni D, Volorio S, et al. Alterations of the notch pathway in lung cancer. Proc Natl Acad Sci U S A. 2009;106:22293–8.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001;61:3200–5.PubMedGoogle Scholar
  40. 40.
    Tilesi F, Fradiani P, Socci V, Willems D, Ascenzioni F. Design and validation of siRNAs and shRNAs. Curr Opin Mol Ther. 2009;11:156–64.PubMedGoogle Scholar
  41. 41.
    Paddison PJ, Hannon GJ. siRNAs and shRNAs: skeleton keys to the human genome. Curr Opin Mol Ther. 2003;5:217–24.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of Pulmonary MedicineThe Affiliated Hospital of Hangzhou Normal UniversityHangzhouChina

Personalised recommendations